Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 12, 2011
NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins
Stephen R Mattarollo, Michelle Yong, Christina Gosmann, et al.
Oncoimmunology
|
May 6, 2015
Co-blockade of immune checkpoints and adenosine A<sub>2A</sub> receptor suppresses metastasis
Arabella Young, Deepak Mittal, Kimberley Stannard, et al.
Cancer Research
|
July 3, 2014
Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor
Deepak Mittal, Arabella Young, Kimberley Stannard, et al.
Plos One
|
March 8, 2013
Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes
Allison Choyce, Michelle Yong, Sharmal Narayan, et al.
Scientific Reports
|
June 1, 2023
Physical and chemical characterization of smokeless tobacco products in India
Priyamvada Sharma, Nuan Ping Cheah, Jagdish Kaur, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2017
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection
Janin Chandra, Julie L Dutton, Bo Li, et al.
Frontiers in Immunology
|
March 4, 2022
Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency
Samantha Chan, Jack Godsell, Miles Horton, et al.
Immunity
|
August 5, 2020
Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma
Maike Effern, Nicole Glodde, Matthias Braun, et al.
The Lancet. Haematology
|
July 1, 2022
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial
Abby Douglas, Karin Thursky, Timothy Spelman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 12, 2011
NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins
Stephen R Mattarollo, Michelle Yong, Christina Gosmann, et al.
Oncoimmunology
|
May 6, 2015
Co-blockade of immune checkpoints and adenosine A<sub>2A</sub> receptor suppresses metastasis
Arabella Young, Deepak Mittal, Kimberley Stannard, et al.
Cancer Research
|
July 3, 2014
Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor
Deepak Mittal, Arabella Young, Kimberley Stannard, et al.
Plos One
|
March 8, 2013
Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes
Allison Choyce, Michelle Yong, Sharmal Narayan, et al.
Scientific Reports
|
June 1, 2023
Physical and chemical characterization of smokeless tobacco products in India
Priyamvada Sharma, Nuan Ping Cheah, Jagdish Kaur, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2017
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection
Janin Chandra, Julie L Dutton, Bo Li, et al.
Frontiers in Immunology
|
March 4, 2022
Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency
Samantha Chan, Jack Godsell, Miles Horton, et al.
Immunity
|
August 5, 2020
Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma
Maike Effern, Nicole Glodde, Matthias Braun, et al.
The Lancet. Haematology
|
July 1, 2022
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial
Abby Douglas, Karin Thursky, Timothy Spelman, et al.
Page
of 2